Wenhao Jiang

Wenhao Jiang

Auto-generated profile, based on publicly available information

Wenhao Jiang

Affiliated Hangzhou First People’s Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, Westlake University, Hangzhou, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZDZhen Dong
Zhen Dong
WJWenhao Jiang
Wenhao Jiang
CWChunlong Wu
Chunlong Wu
TCTing Chen
Ting Chen
JCJiayi Chen
Jiayi Chen
TGTiannan Guo
Tiannan Guo
Hydrogel-based tissue expansion combined with mass spectrometry (MS) offers an emerging spatial proteomics approach. Here, we present a filter-aided expansion proteomics (FAXP) strategy for spatial proteomics analysis of archived formalin-fixed paraffin-embedded (FFPE) specimens. Compared to our previous ProteomEx method, FAXP employed a customized tip device to enhance both the stability and throughput of sample preparation, thus guaranteeing the reproducibility and robustness of the workflow. FAXP achieved a 14.5-fold increase in volumetric resolution. It generated over 8 times higher peptide yield and a 255% rise in protein identifications while reducing sample preparation time by 50%. We also demonstrated the applicability of FAXP using human colorectal FFPE tissue samples. Furthermore, for the first time, we achieved bona fide single-subcellular proteomics under image guidance by integrating FAXP with laser capture microdissection.

21 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHuanhuan Gao
Huanhuan Gao
YZYi Zhu
Yi Zhu
DWDongxue Wang
Dongxue Wang
ZNZongxiang Nie
Zongxiang Nie
HWHe Wang
He Wang
TGTiannan Guo
Tiannan Guo
Quality control (QC) in mass spectrometry (MS)-based proteomics is mainly based on data-dependent acquisition (DDA) analysis of standard samples. Here, we collect 2754 files acquired by data independent acquisition (DIA) and paired 2638 DDA files from mouse liver digests using 21 mass spectrometers across nine laboratories over 31 months. Our data demonstrate that DIA-based LC-MS/MS-related consensus QC metrics exhibit higher sensitivity compared to DDA-based QC metrics in detecting changes in LC-MS status. We then prioritize 15 metrics and invite 21 experts to manually assess the quality of 2754 DIA files based on those metrics. We develop an AI model for DIA-based QC using 2110 training files. It achieves AUCs of 0.91 (LC) and 0.97 (MS) in the first validation dataset (n = 528), and 0.78 (LC) and 0.94 (MS) in an independent validation dataset (n = 116). Finally, we develop an offline software called iDIA-QC for convenient adoption of this methodology.

9 October 2025 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
ZDZhen Dong
Zhen Dong
CWChunlong Wu
Chunlong Wu
JCJiayi Chen
Jiayi Chen
WJWenhao Jiang
Wenhao Jiang
KPKiryl Piatkevich
Kiryl Piatkevich
TGTiannan Guo
Tiannan Guo

17 June 2026 in Nature
Verified
Journal Article
Open access
LYLiang Yue
Liang Yue
WJWenhao Jiang
Wenhao Jiang
SLSainan Li
Sainan Li
MLMeng Luo
Meng Luo
NFNing Fan
Ning Fan
TGTiannan Guo
Tiannan Guo
A detailed, spatially resolved quantitative map of the human proteome is essential for a deeper understanding of human biology and disease 1–4 . Here we present a comprehensive human proteomic landscape, generated by profiling more than 13,000 proteins across 2,856 samples using data-independent acquisition mass spectrometry. The dataset spans 58 major tissue types, 251 specific tissue subtypes and 25 distinct carcinomas. This resource enables the depiction of spatially resolved proteome trajectories across tissue types and physiological states, including fetal, tumour, adjacent non-tumour and healthy adult tissue, thereby providing insight into both developmental processes and oncogenic progression. Furthermore, quantitative proteomics comparisons across diverse tissue types and states facilitate the indication of organ-specific toxicity, the identification of repurposable anticancer drug candidates and the prioritization of therapeutic targets for cancers. This study establishes a quantitative resource for navigating the proteome in the human body and in common cancers.

28 December 2024 in Scientific Data
Verified
Journal Article
Open access
PDF file
LLLu Li
Lu Li
WJWenhao Jiang
Wenhao Jiang
WWWenjun Wei
Wenjun Wei
GKGnana P. Krishnamoorthy
Gnana P. Krishnamoorthy
PHPingping Hu
Pingping Hu
YSYaoting Sun
Yaoting Sun
Thyroid nodules are a common endocrine condition with an increasing incidence over the decades. Data-independent acquisition has been widely utilized in discovery proteomics to identify disease biomarkers and therapeutic targets. To analyze the thyroid disease-related proteome in a high-throughput, reproducible and reliable manner, we introduce thyroid-specific peptide spectral libraries. Here, we generated four deep-coverage libraries through four mass spectrometers comprising Q Exactive HF, Orbitrap Exploris 480, ZenoTOF 7600, and timsTOF Pro. These libraries encompass over 215,000 precursors, 172,000 peptides, and 12,000 proteins, derived from 245 tissue samples across nine histological types and 50 cell lines across six histological types. Moreover, the spectral libraries are applied to nine types of thyroid samples to facilitate the exploration of disease-specific proteins. Our spectral libraries serve as a valuable resource for analyzing thyroid protein content, facilitating deeper insights into thyroid disorders.

1 December 2025 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
ZDZhen Dong
Zhen Dong
WXWeirong Xiang
Weirong Xiang
WJWenhao Jiang
Wenhao Jiang
TGTiannan Guo
Tiannan Guo
Tissue expansion, originally developed for super-resolution imaging, has become a foundation for expansion omics (ExO), a growing field that uses physical tissue expansion to enable spatially resolved omics profiling. In this perspective, we explore how ExO integrates multi-omics through chemical anchoring strategies that ensure selective retention of diverse molecular species, together with improved spatial resolution from the subcellular resolution for profiling to the sub-nanometer scale for imaging, allowing precise detection of biomolecules and their link with biological function. These capabilities have empowered tissue expansion to be successfully applied across multiple spatial omics modalities, including epigenomics, transcriptomics, proteomics, and lipidomics, enabling high-resolution mapping of chromatin states, gene expression, protein localization, and lipid distributions. Moreover, ExO supports spatial multi-omics approaches that jointly capture and correlate multiple biomolecular dimensions within the same tissue context. However, challenges remain in expansion resolution, molecular retention, hydrogel adaptability, data scalability, and AI-driven analysis. As tissue expansion evolves, its integration of super-resolution imaging and spatial omics establishes it as a core technology for whole-slide, single-cell multi-omics and the development of the Artificial Intelligence Virtual Cell, advancing spatial biology and medicine.